Firstly, the molecular background evaluation of dysfunction in the NRF2 and NOTCH pathways represents a first interesting step to verifying and better understanding the features of KEAP1–NRF2/NOTCH interaction and clarifying its role in SCLC tumorigenesis. This evidence concerns the gene NFE2L2 and small cell lung carcinoma.